Sensors and Actuators B 126 (2007) 387–393
New sensing technology for detection of the common inhalational
anesthetic agent sevoflurane using conducting polypyrrole films
Ren-Jang Wu
a,∗
, Yu-Ching Huang
a
, Murthy Chavali
b
,
Tzu Hsuan Lin
c
, Shih-Lin Hung
c
, Hsiang-Ning Luk
d
a
Department of Applied Chemistry, Providence University, 200 Chungchi Road, Shalu, Taichung Hsien 433, Taiwan, ROC
b
Environmental Techniques Center, U-CAN Dynatex Inc., No. 95 Nankang 3rd Road, Nankang Ind. Park, Nantou City 540, Taiwan, ROC
c
Department of Civil Engineering, National Chiao Tung University, Hsinchu 300, Taiwan, ROC
d
Department of Anesthesiology, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
Received 27 August 2006; received in revised form 17 March 2007; accepted 19 March 2007
Available online 27 March 2007
Abstract
A new type of gas sensor to measure resistance was developed to detect sevoflurane concentrations at room temperature. The measured FTIR
spectrum of sevoflurane vapor was given. The sensing material polypyrrole was synthesized in situ by UV-photopolymerization. The relative
resistance variation was 3.9 for a sevoflurane concentration of 1.2%. The sensor response time (60 s) and recovery time (20 s) were very short.
Molecular dynamic calculations made for sevoflurane adsorption on polypyrrole revealed formation of a new bond, N–H–F. The bond length was
predicted to be in the range of 0.2–0.4 nm. The bond energy was about 7.2 kcal/mol. Sensor responses to the concentrations 0.1–10% were 1.57–5.9,
respectively.
© 2007 Elsevier B.V. All rights reserved.
Keywords: Sevoflurane; Polypyrrole; Conducting polymer; UV-photopolymerization; VOC sensor
1. Introduction
Among numerous inhalational anesthetic agents in cur-
rent use are potent volatile liquids of halogenated derivatives
of alkanes, particularly halothane (CF
3
CHClBr; 1956 as flu-
orothane), the halogenated derivatives of ethers, especially
enflurane (CHClFCF
2
OCHF
2
; 1972 as ethrane), the malodor-
ous isoflurane (CF
3
CHClOCHF
2
; 1981 as forane), the more
volatile but equally malodorous desflurane (CF
3
CHFOCHF
2
;
1992 as suprane), and lastly the non-irritating, sweet to taste,
highly insoluble sevoflurane (C
4
H
3
F
7
O; 1990 as ultane). All
play vital roles in the pain management of patients undergoing
surgery [1–4].
The most commonly used inhalational anesthetic agent,
sevoflurane, is a fluorinated derivative of methyl isopropyl ether
(International Union and Applied Chemistry, IUPAC nomen-
clature; fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl
∗
Corresponding author. Tel.: +886 4 26328001x15212; fax: +886 4 26327554.
E-mail address: rjwu@pu.edu.tw (R.-J. Wu).
ether). Its structure is shown in Fig. 1. Owing to its many med-
ical applications, sevoflurane has rapidly replaced halothane
as an inhaled anesthetic agent. Its benefits include a quick
induction and emergence from anesthesia, a non-pungent odor,
allowing for mask induction, and decreased airway irritation.
On the downside are several side effects, including seizures
during induction and maintenance, elevation in plasma, and
an increased incidence of emergence delirium over halothane.
Monitoring the concentration of sevoflurane, particularly in the
surgical wards where support staff may be exposed, is essen-
tial. In recent times, measuring the concentration of sevoflurane
in blood and in clinical inhalation has become important [5,6].
Exposure to waste anesthetic gases can strongly impact workers
in operating rooms, dental offices, and veterinary offices. It has
also been reported that some of the highest levels of waste anes-
thetic gases have been found in post-operative recovery rooms
[1(b)].
Several instrumental techniques, such as simple gas
chromatography and hyphenated/coupled methods like gas
chromatography-mass spectrometry (GC–MS), are applied to
the detection of concentrations of sevoflurane in blood [5–7]. Ho
0925-4005/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.snb.2007.03.026